Egerer G - Search Results

1

Concomitant gain of 1q21 and MYC translocation define a poor prognostic subgroup of hyperdiploid multiple myeloma.

Weinhold N, Kirn D, Seckinger A, Hielscher T, Granzow M, Bertsch U, Egerer G, Salwender H, Blau IW, Weisel K, Hillengass J, Raab MS, Hose D, Goldschmidt H, Jauch A. Weinhold N, et al. Among authors: egerer g. Haematologica. 2016 Mar;101(3):e116-9. doi: 10.3324/haematol.2015.136929. Epub 2015 Nov 26. Haematologica. 2016. PMID: 26611471 Free PMC article. Clinical Trial. No abstract available.

2

Autologous retransplantation for patients with recurrent multiple myeloma: a single-center experience with 200 patients.

Sellner L, Heiss C, Benner A, Raab MS, Hillengass J, Hose D, Lehners N, Egerer G, Ho AD, Goldschmidt H, Neben K. Sellner L, et al. Among authors: egerer g. Cancer. 2013 Jul 1;119(13):2438-46. doi: 10.1002/cncr.28104. Epub 2013 Apr 10. Cancer. 2013. PMID: 23576287 Free article.

3

Autologous stem cell transplantation for elderly patients with newly diagnosed multiple myeloma in the era of novel agents.

Merz M, Neben K, Raab MS, Sauer S, Egerer G, Hundemer M, Hose D, Kunz C, Heiß C, Ho AD, Goldschmidt H, Hillengass J. Merz M, et al. Among authors: egerer g. Ann Oncol. 2014 Jan;25(1):189-95. doi: 10.1093/annonc/mdt509. Ann Oncol. 2014. PMID: 24356629 Free article.

4

Predictive value of longitudinal whole-body magnetic resonance imaging in patients with smoldering multiple myeloma.

Merz M, Hielscher T, Wagner B, Sauer S, Shah S, Raab MS, Jauch A, Neben K, Hose D, Egerer G, Weber MA, Delorme S, Goldschmidt H, Hillengass J. Merz M, et al. Among authors: egerer g. Leukemia. 2014 Sep;28(9):1902-8. doi: 10.1038/leu.2014.75. Epub 2014 Feb 18. Leukemia. 2014. PMID: 24535407

5

Prognostic significance of focal lesions in whole-body magnetic resonance imaging in patients with asymptomatic multiple myeloma.

Hillengass J, Fechtner K, Weber MA, Bäuerle T, Ayyaz S, Heiss C, Hielscher T, Moehler TM, Egerer G, Neben K, Ho AD, Kauczor HU, Delorme S, Goldschmidt H. Hillengass J, et al. Among authors: egerer g. J Clin Oncol. 2010 Mar 20;28(9):1606-10. doi: 10.1200/JCO.2009.25.5356. Epub 2010 Feb 22. J Clin Oncol. 2010. PMID: 20177023

6

Hepatitis B virus infection is associated with deletion of chromosome 8p in multiple myeloma.

Becker N, Byl A, Friedrich S, Jauch A, Schnitzler P, Egerer G, Ho AD, Goldschmidt H, Neben K. Becker N, et al. Among authors: egerer g. Eur J Haematol. 2013 Apr;90(4):279-85. doi: 10.1111/ejh.12018. Epub 2012 Nov 22. Eur J Haematol. 2013. PMID: 23033960

7

Dose-intensified bendamustine followed by autologous peripheral blood stem cell support in relapsed and refractory multiple myeloma with impaired bone marrow function.

Breitkreutz I, Becker N, Benner A, Kosely F, Heining C, Hillengass J, Egerer G, Ho AD, Goldschmidt H, Raab MS. Breitkreutz I, et al. Among authors: egerer g. Hematol Oncol. 2016 Dec;34(4):200-207. doi: 10.1002/hon.2199. Epub 2015 Mar 18. Hematol Oncol. 2016. PMID: 25784529

8

Bisphosphonate treatment and renal function in 201 myeloma patients undergoing stem cell transplantation.

Schmitt S, Hielscher T, Baldus C, Neben K, Egerer G, Hillengaß J, Raab M, Hose D, Ho AD, Bergner R, Goldschmidt H, Moehler TM. Schmitt S, et al. Among authors: egerer g. Int J Hematol. 2013 Jun;97(6):765-72. doi: 10.1007/s12185-013-1320-1. Epub 2013 Apr 25. Int J Hematol. 2013. PMID: 23616219

9

Single versus tandem high-dose melphalan followed by autologous blood stem cell transplantation in multiple myeloma: long-term results from the phase III GMMG-HD2 trial.

Mai EK, Benner A, Bertsch U, Brossart P, Hänel A, Kunzmann V, Naumann R, Neben K, Egerer G, Ho AD, Hillengass J, Raab MS, Neubauer A, Peyn A, Ko YD, Peter N, Scheid C, Goldschmidt H. Mai EK, et al. Among authors: egerer g. Br J Haematol. 2016 Jun;173(5):731-41. doi: 10.1111/bjh.13994. Epub 2016 Mar 17. Br J Haematol. 2016. PMID: 26990892 Free article. Clinical Trial.

10

Increased risk of catheter colonization and catheter-related infections in severe immunocompromized patients with multiple myeloma undergoing high-dose glucocorticoid treatment.

Goldschmidt H, Salwender HJ, Hahn U, Hegenbart U, Egerer G, Wallmeier M, Jansen B, Haas R. Goldschmidt H, et al. Among authors: egerer g. Zentralbl Bakteriol. 1998 Jan;287(1-2):125-34. doi: 10.1016/s0934-8840(98)80158-8. Zentralbl Bakteriol. 1998. PMID: 9532271

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

195 results

Search Page

Filters